|
1
|
Bacci G, Longhi A, Bertoni F, Briccoli A,
Versari M, Pignotti E and Picci P: Bone metastases in osteosarcoma
patients treated with neoadjuvant or adjuvant chemotherapy: The
Rizzoli experience in 52 patients. Acta Orthop. 77:938–943. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bielack SS, Kempf-Bielack B, Delling G,
Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M,
Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma
of the extremities or trunk: An analysis of 1,702 patients treated
on neoadjuvant cooperative osteosarcoma study group protocols. J
Clin Oncol. 20:776–790. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ruan K, Song G and Ouyang G: Role of
hypoxia in the hallmarks of human cancer. J Cell Biochem.
107:1053–1062. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tan C, Zhang L, Cheng X, Lin XF, Lu RR,
Bao JD and Yu HX: Curcumin inhibits hypoxia-induced migration in K1
papillary thyroid cancer cells. Exp Biol Med (Maywood).
240:925–935. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mizobuchi H, Garcia-Castellano JM, Philip
S, Healey JH and Gorlick R: Hypoxia markers in human osteosarcoma:
An exploratory study. Clin Orthop Relat Res. 466:2052–2059. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen Y, Wang CM, Shi YQ and Yang Y:
Expression of hypoxia-inducible factor 1alpha in osteosarcoma and
its value in predicting chemosensitivity. Zhonghua Zhong Liu Za
Zhi. 34:899–904. 2012.(In Chinese). PubMed/NCBI
|
|
7
|
Yang QC, Zeng BF, Dong Y, Shi ZM, Jiang ZM
and Huang J: Overexpression of hypoxia-inducible factor-1alpha in
human osteosarcoma: Correlation with clinicopathological parameters
and survival outcome. Jpn J Clin Oncol. 37:127–134. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Al-Hussaini H, Subramanyam D, Reedijk M
and Sridhar SS: Notch signaling pathway as a therapeutic target in
breast cancer. Mol Cancer Ther. 10:9–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong Y, Jesse AM, Kohn A, Gunnell LM,
Honjo T, Zuscik MJ, O'Keefe RJ and Hilton MJ: RBPjkappa-dependent
Notch signaling regulates mesenchymal progenitor cell proliferation
and differentiation during skeletal development. Development.
137:1461–1471. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qiang L, Wu T, Zhang HW, Lu N, Hu R, Wang
YJ, Zhao L, Chen FH, Wang XT, You QD and Guo QL: HIF-1a is critical
for hypoxia-mediated maintenance of glioblastoma stem cells by
activating Notch signaling pathway. Cell Death Differ. 19:284–294.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Singh S and Khar A: Biological effects of
curcumin and its role in cancer chemoprevention and therapy.
Anticancer Agents Med Chem. 6:259–270. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Panchal HD, Vranizan K, Lee CY, Ho J, Ngai
J and Timiras PS: Early anti-oxidative and anti-proliferative
curcumin effects on neuroglioma cells suggest therapeutic targets.
Neurochem Res. 33:1701–1710. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kurup VP and Barrios CS: Immunomodulatory
effects of curcumin in allergy. Mol Nutr Food Res. 52:1031–1039.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim DC, Ku SK and Bae JS: Anticoagulant
activities of curcumin and its derivative. BMB Rep. 45:221–226.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Dou X, Fan C, Wo L, Yan J, Qian Y and Wo
X: Curcumin up-regulates LDL receptor expression via the sterol
regulatory element pathway in HepG2 cells. Planta Med.
74:1374–1379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shishodia S, Chaturvedi MM and Aggarwal
BB: Role of curcumin in cancer therapy. Curr Probl Cancer.
31:243–305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang YJ, Huang CY, Hung CS, Chen WY and
Wei PL: GRP78 mediates the therapeutic efficacy of curcumin on
colon cancer. Tumour Biol. 36:633–641. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ye M and Zhang J and Zhang J, Miao Q, Yao
L and Zhang J: Curcumin promotes apoptosis by activating the
p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer.
Cancer Lett. 357:196–205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Amin AR, Haque A, Rahman MA, Chen ZG,
Khuri FR and Shin DM: Curcumin induces apoptosis of upper
aerodigestive tract cancer cells by targeting multiple pathways.
PLoS One. 10:e01242182015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C (T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao X, Gao S, Ren H, Sun W, Zhang H, Sun
J, Yang S and Hao J: Hypoxia-inducible factor-1 promotes pancreatic
ductal adenocarcinoma invasion and metastasis by activating
transcription of the actin-bundling protein fascin. Cancer Res.
74:2455–2464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu N, Wang Y, Zhou Y, Pang H, Zhou J,
Qian P, Liu L and Zhang H: Kruppel-like factor 8 involved in
hypoxia promotes the invasion and metastasis of gastric cancer via
epithelial to mesenchymal transition. Oncol Rep. 32:2397–2404.
2014.PubMed/NCBI
|
|
23
|
Sahlgren C, Gustafsson MV, Jin S,
Poellinger L and Lendahl U: Notch signaling mediates
hypoxia-induced tumor cell migration and invasion. Proc Natl Acad
Sci USA. 105:6392–6397. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Broadhead ML, Clark JC, Myers DE, Dass CR
and Choong PF: The molecular pathogenesis of osteosarcoma: A
review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
He JP, Hao Y, Wang XL, Yang XJ, Shao JF,
Guo FJ and Feng JX: Review of the molecular pathogenesis of
osteosarcoma. Asian Pac J Cancer Prev. 15:5967–5976. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
El NA, Clarkson P, Zhang F, Mathers J,
Tognon C and Sorensen PH: Expression and stability of hypoxia
inducible factor 1a in osteosarcoma. Pediatr Blood Cancer.
59:1215–1222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Koh MY, Spivak-Kroizman TR and Powis G:
HIF-1alpha and cancer therapy. Recent Results Cancer Res.
180:15–34. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao H, Wu Y, Chen Y and Liu H: Clinical
significance of hypoxia-inducible factor 1 and VEGF-A in
osteosarcoma. Int J Clin Oncol. 20:1233–1243. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nelson DA, Tan TT, Rabson AB, Anderson D,
Degenhardt K and White E: Hypoxia and defective apoptosis drive
genomic instability and tumorigenesis. Genes Dev. 18:2095–2107.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Moeller BJ, Cao Y, Vujaskovic Z, Li CY,
Haroon ZA and Dewhirst MW: The relationship between hypoxia and
angiogenesis. Semin Radiat Oncol. 14:215–221. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gu Q, He Y, Ji J, Yao Y, Shen W, Luo J,
Zhu W, Cao H, Geng Y, Xu J, et al: Hypoxia-inducible factor 1a
(HIF-1a) and reactive oxygen species (ROS) mediates
radiation-induced invasiveness through the SDF-1a/CXCR4 pathway in
non-small cell lung carcinoma cells. Oncotarget. 6:10893–10907.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu X and Kang Y: Hypoxia and
hypoxia-inducible factors: Master regulators of metastasis. Clin
Cancer Res. 16:5928–5935. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim M, Park SY, Pai HS, Kim TH, Billiar TR
and Seol DW: Hypoxia inhibits tumor necrosis factor-related
apoptosis-inducing ligand-induced apoptosis by blocking Bax
translocation. Cancer Res. 64:4078–4081. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bel Aiba RS, Dimova EY, Görlach A and
Kietzmann T: The role of hypoxia inducible factor-1 in cell
metabolism-a possible target in cancer therapy. Expert Opin Ther
Targets. 10:583–599. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Selvendiran K, Bratasz A, Kuppusamy ML,
Tazi MF, Rivera BK and Kuppusamy P: Hypoxia induces chemoresistance
in ovarian cancer cells by activation of signal transducer and
activator of transcription 3. Int J Cancer. 125:2198–2204. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zou YM, Hu GY, Zhao XQ, Lu T, Zhu F, Yu SY
and Xiong H: Hypoxia-induced autophagy contributes to
radioresistance via c-Jun-mediated Beclin1 expression in lung
cancer cells. J Huazhong Univ Sci Technolog Med Sci. 34:761–767.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guan G, Zhang Y, Lu Y, Liu L, Shi D, Wen
Y, Yang L, Ma Q, Liu T, Zhu X, et al: The HIF-1a/CXCR4 pathway
supports hypoxia-induced metastasis of human osteosarcoma cells.
Cancer Lett. 357:254–264. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun Y, Wang H, Liu M, Lin F and Hua J:
Resveratrol abrogates the effects of hypoxia on cell proliferation,
invasion and EMT in osteosarcoma cells through downregulation of
the HIF-1α protein. Mol Med Rep. 11:1975–1981. 2015.PubMed/NCBI
|
|
39
|
Shehzad A, Wahid F and Lee YS: Curcumin in
cancer chemoprevention: Molecular targets, pharmacokinetics,
bioavailability, and clinical trials. Arch Pharm (Weinheim).
343:489–499. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Duan W, Chang Y, Li R, Xu Q, Lei J, Yin C,
Li T, Wu Y, Ma Q and Li X: Curcumin inhibits hypoxia inducible
factor-1α-induced epithelial-mesenchymal transition in HepG2
hepatocellular carcinoma cells. Mol Med Rep. 10:2505–2510.
2014.PubMed/NCBI
|
|
41
|
Wang L, Jin F, Qin A, Hao Y, Dong Y, Ge S
and Dai K: Targeting Notch1 signaling pathway positively affects
the sensitivity of osteosarcoma to cisplatin by regulating the
expression and/or activity of Caspase family. Mol Cancer.
13:1392014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tao J, Jiang MM, Jiang L, Salvo JS, Zeng
HC, Dawson B, Bertin TK, Rao PH, Chen R, Donehower LA, et al: Notch
activation as a driver of osteogenic sarcoma. Cancer Cell.
26:390–401. 2014. View Article : Google Scholar : PubMed/NCBI
|
